Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 1419-1426, May 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McMillan, P. J.
Right arrow Articles by Roos, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMillan, P. J.
Right arrow Articles by Roos, B. A.

Immunohistology, Light Microscopy, and Ultrastructural Morphology of Transplantable Rat Medullary Thyroid Carcinomas1

P. J. McMillan2, L. G. Thaete, W. M. Hooker and B. A. Roos

Department of Anatomy, Loma Linda University, Loma Linda, California 92350 [P. J. M., L. G. T., W. M. H.], and Endocrinology and Mineral Metabolism, Veterans Administration Medical Center and School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106 [B. A. R.]

We recently reported growth and calcitonin (CT) parameters determined during serial transplantation of rat medullary thyroid carcinoma (MTC). After 6 to 8 tumor transplant generations, most MTC series tended to maintain characteristic rates of growth and CT production. We have selected three stable MTC series which together represent a wide range of growth and CT production for immunohistological, light microscopic, and ultrastructural analyses. These analyses have been interpreted in light of previously reported biological and immunochemical characteristics of these tumors. The fastest growing MTC series (designated 1-1-2) has the lowest CT content. The two other MTC series, 1-2-4 and 2-2-10, have somewhat slower growth and 10- to 20-fold higher CT content.

Descriptive light microscopic analyses of the tumors distinguished the 1-1-2 series by the presence of active necrosis and scar tissue and by generalized low-intensity immunoperoxidase staining (CT antibodies). Descriptive ultrstructural analyses revealed high concentrations of secretory granules in each of the 3 MTC series. However, differences in morphology and distribution of secretory granules and other cell organelles related to processing and elaboration of secretory products were noted. The highest CT-producers (MTC Series 2-2-10) had, in addition to mature secretory granules, a number of less mature, more electron-dense, prosecretory-type granules near the Golgi apparatus. Secretory granules in the 2-2-10 series tumor cells were distributed more peripherally than in the 1-2-4 series. Compared to the 2-2-10 series, the 1-2-4 series exhibited a similar number of coated and prosecretory-type vesicles in the Golgi region. The uniform staining and distribution of mature secretory granules and dilated rough endoplasmic reticulum with few attached ribosomes characterized the 1-2-4 series. The low-CT, fast-growing 1-1-2 tumors exhibited decreased mitochondria, increased lysosomes, and increased microfilaments. They also had features of cells actively elaborating secretory products such as peripheral secretory granules with varying density and prominent dilated Golgi profiles. The prosecretory-type granules, however, occupied a similar volume in this series as in 1-2-4 and 2-2-10. These results suggest that the type of secretory products and their rate of synthesis may differ among the MTC tumors, making these tumors an excellent model system for studying tumor growth and function.

1 This work was supported by American Cancer Society Grant BC282 to Case Western Reserve University, in part by NIH Grant RR00276 to Loma Linda University, and by the Veterans Administration.

2 To whom requests for reprints should be addressed.

Received 6/11/79. Accepted 1/29/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.